What is Spyre Therapeutics, Inc.'s total debt?

Spyre Therapeutics, Inc. (SYRE) reported total debt of $4.33M in Q2 2023.

How has Spyre Therapeutics, Inc.'s total debt changed year-over-year?

Spyre Therapeutics, Inc.'s total debt decreased by 9.6% year-over-year, from $4.79M to $4.33M.

What is the long-term trend for Spyre Therapeutics, Inc.'s total debt?

Over 2 years (2020 to 2022), Spyre Therapeutics, Inc.'s total debt has grown at a -8.3% compound annual growth rate (CAGR), from $5.52M to $4.65M.

Spyre Therapeutics, Inc. SYRE Total debt

Discontinued — last reported Q2 '23

Total debt at other companies

Bristol-Myers SquibbBMY

——

Eli LillyLLY

——

PfizerPFE

——

Johnson & JohnsonJNJ

——

Merck & Co.MRK

——

AbbVieABBV

——

Other financials

Income statement

See full

Revenue-—

Operating income-$45.6M+14.8%

Net income-$69.0M-54.1%

EPS (diluted)-$0.74-23.3%

Balance sheet

See full

Cash & equivalents$97.2M+100%

Total equity$670.8M+39.0%

Total assets$764.0M+34.1%

Cash flow

See full

Operating cash flow-$57.4M-40.0%

CapEx-—

Free cash flow-$39.4M-26.8%

Valuation

See full

Market cap$7.67B+307%

Profitability

See full

Operating margin-39,428.9%-49,795pp

Net margin-52,939.7%-61,871pp

FCF margin-3,442.8%-3,807pp

Returns & leverage

See full

Return on equity-31.1%-10.7pp

Debt / equity0.1×+0.1×

Current ratio9×+0.9×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $4.33M.

The official record: Spyre Therapeutics, Inc.’s 10-Q, filed August 11, 2023, on SEC EDGAR. View the filing →

Ask your AI about Spyre Therapeutics, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Spyre Therapeutics, Inc.'s total debt?: Spyre Therapeutics, Inc. (SYRE) reported total debt of $4.33M in Q2 2023.
How has Spyre Therapeutics, Inc.'s total debt changed year-over-year?: Spyre Therapeutics, Inc.'s total debt decreased by 9.6% year-over-year, from $4.79M to $4.33M.
What is the long-term trend for Spyre Therapeutics, Inc.'s total debt?: Over 2 years (2020 to 2022), Spyre Therapeutics, Inc.'s total debt has grown at a -8.3% compound annual growth rate (CAGR), from $5.52M to $4.65M.